Prevalence of erectile dysfunction in type 2 diabetes mellitus (T2DM) and its predictors among diabetic men
Boehringer Ingelheims Survodutide Survodutide (BI 456906), co-invented by Boehringer Ingelheim and Zealand Pharma, is an investigational glucagon/GLP-1 receptor dual agonist
Andres Splenser, MD, an endocrinologist affiliated with Memorial Hermann, also not involved in the study, told MNT that, if a patient with [type 2 diabetes] also has depression, this can affect their motivation to eat healthy, exercise, and impact compliance with taking their medications. Today, however, there are many treatment options for diabetes that allow patients to remain healthy and not have to deal with any [diabetes] complications in their lifetime as long as their blood glucose values are well controlled, he added
Lyophilized BPC 157 powder is relatively stable when stored cold and dry
This was a controlled laboratory study, not a human-use trial
(980) 306-2060 Treatment recommendations are individualized and based on medical evaluation, health history, medication safety considerations, insurance coverage, medication availability, and clinician judgment.